Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation
Yun, Y.S.; Kim, B.J.; Hong, S.P.; Lee, T.W.; Lim, C.G.; Kim, M.J.
Transplantation Proceedings 28(3): 1561-1564
1996
ISSN/ISBN: 0041-1345 PMID: 8658786 Document Number: 463241
Document emailed within 1 workday
Related Documents
Scrimgeour, E.; Anderson, J.D. 1985: Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses South African Medical Journal 67(26): 1044-1045Heaf, J. 1993: Bone marrow function during quadruple immunosuppressive therapy after renal transplantation Clinical Nephrology 40(6): 332-338
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27
Ganapiev, A.A.; Golubovskaia, I.K.; Zalialov, I.R.; Estrina, M.A.; Afanas'ev, B.V. 2010: The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia Terapevticheskii Arkhiv 82(7): 48-52
Arranz, R.; Otero, M.J.; Ramos, R.; Steegmann, J.L.; Lamana, M.L.; Tomás, J.F.; de la Cámara, R.; Figuera, A.; Vázquez, L.; Fernádez-Rañada, J.M. 1994: Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy Bone Marrow Transplantation 13(4): 383-387
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621
Boner, G.; Kristal, H. 1983: Neoplastic disease in patients receiving dialytic therapy and in patients after receiving transplantation Harefuah 104(2): 68-69
Heering, P.; Westhoff, A.; Ivens, K.; Kutkuhn, B.; Grabensee, B. 1994: Reduction of immunosuppressive therapy after renal transplantation: a randomized study Transplantation Proceedings 26(5): 2530-2532
Caletti, C.; Granata, S.; Tomei, P.; Dalla Gassa, A.; Lupo, A.; Zaza, G. 2015: Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 32(3)
Jiménez, S.; Zamora, J.; Muriel, A.; Pascual, J. 2008: Is it possible to sustain adequate immunosuppressive efficacy minimizing the nephrotoxicity with a regimen including low doses of calcineurin inhibitors or sirolimus? Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 2): 40-41
Olivari, M.T.; Homans, D.C.; Wilson, R.F.; Kubo, S.H.; Ring, W.S. 1989: Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy Circulation 80(5 Part 2): Iii111-5
Canafax, D.M.; Carleton, B.C.; Matas, A.J.; Payne, W.D.; Dunn, D.L.; Sutherland, D.E.; Najarian, J.S. 1993: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy Transplantation Proceedings 25(1 Pt 2): 1692-1693
Kountz, S.L.; Rao, T.K. 1974: Bolus doses of steroids in transplantation Proceedings of the Clinical Dialysis and Transplant Forum 4: 90-95
Gupta, K.L.; Ghosh, A.K.; Kochhar, R.; Jha, V.; Chakrabarti, A.; Sakhuja, V. 1994: Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols American Journal of Gastroenterology 89(7): 1062-1065
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Neuhaus, P.; Klupp, J.; Langrehr, J.M.; Neumann, U.; Gebhardt, A.; Pratschke, J.; Tullius, S.G.; Lohmann, R.; Radke, C.; Rayes, N.; Neuhaus, R.; Bechstein, W.O. 2000: Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial Transplantation 69(11): 2343-2353
Ruffault, A.; Fauconnier, B.; Cartier, F.; Launois, B. 1975: Herpes simplex virus antibodies in 18 patients submitted to immunosuppressive agents after renal transplantation Pathologie-Biologie 23(5): 371-374
Sagynbaeva, V.É; Lazebnik, L.B. 2013: Immunosuppressive effect of bone marrow MSC transplantation in patients with ulcerative colitis with six kinds of one family autoantibodies with cross-relationship between each other Eksperimental'naia i Klinicheskaia Gastroenterologiia 9: 34-39
Amenábar, J.J.; Gómez-Ullate, P.; García-López, F.J.; Aurrecoechea, B.; García-Erauzkin, G.; Lampreabe, I. 1998: A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation Transplantation 65(5): 653-661
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816